These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 29102090

  • 1. Comprehensive genomic profiling reveals inactivating SMARCA4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type.
    Lin DI, Chudnovsky Y, Duggan B, Zajchowski D, Greenbowe J, Ross JS, Gay LM, Ali SM, Elvin JA.
    Gynecol Oncol; 2017 Dec; 147(3):626-633. PubMed ID: 29102090
    [Abstract] [Full Text] [Related]

  • 2. Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis.
    Auguste A, Blanc-Durand F, Deloger M, Le Formal A, Bareja R, Wilkes DC, Richon C, Brunn B, Caron O, Devouassoux-Shisheboran M, Gouy S, Morice P, Bentivegna E, Sboner A, Elemento O, Rubin MA, Pautier P, Genestie C, Cyrta J, Leary A.
    Cells; 2020 Jun 19; 9(6):. PubMed ID: 32575483
    [Abstract] [Full Text] [Related]

  • 3. Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: Clinical features of a single family and comparison of large cohorts.
    Connor YD, Miao D, Lin DI, Hayne C, Howitt BE, Dalrymple JL, DeLeonardis KR, Hacker MR, Esselen KM, Shea M.
    Gynecol Oncol; 2020 Apr 19; 157(1):106-114. PubMed ID: 31954538
    [Abstract] [Full Text] [Related]

  • 4. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
    Karnezis AN, Wang Y, Ramos P, Hendricks WP, Oliva E, D'Angelo E, Prat J, Nucci MR, Nielsen TO, Chow C, Leung S, Kommoss F, Kommoss S, Silva A, Ronnett BM, Rabban JT, Bowtell DD, Weissman BE, Trent JM, Gilks CB, Huntsman DG.
    J Pathol; 2016 Feb 19; 238(3):389-400. PubMed ID: 26356327
    [Abstract] [Full Text] [Related]

  • 5. Biallelic somatic SMARCA4 mutations in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).
    Bailey S, Murray MJ, Witkowski L, Hook E, Hasselblatt M, Crawford R, Foulkes WD, Tischkowitz M, Nicholson JC.
    Pediatr Blood Cancer; 2015 Apr 19; 62(4):728-30. PubMed ID: 25307865
    [Abstract] [Full Text] [Related]

  • 6. Small-Cell Carcinoma of the Ovary of Hypercalcemic Type (Malignant Rhabdoid Tumor of the Ovary): A Review with Recent Developments on Pathogenesis.
    Witkowski L, Goudie C, Foulkes WD, McCluggage WG.
    Surg Pathol Clin; 2016 Jun 19; 9(2):215-26. PubMed ID: 27241105
    [Abstract] [Full Text] [Related]

  • 7. Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor.
    Fahiminiya S, Witkowski L, Nadaf J, Carrot-Zhang J, Goudie C, Hasselblatt M, Johann P, Kool M, Lee RS, Gayden T, Roberts CW, Biegel JA, Jabado N, Majewski J, Foulkes WD.
    Oncotarget; 2016 Jan 12; 7(2):1732-40. PubMed ID: 26646792
    [Abstract] [Full Text] [Related]

  • 8. Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism.
    Orlando KA, Douglas AK, Abudu A, Wang Y, Tessier-Cloutier B, Su W, Peters A, Sherman LS, Moore R, Nguyen V, Negri GL, Colborne S, Morin GB, Kommoss F, Lang JD, Hendricks WP, Raupach EA, Pirrotte P, Huntsman DG, Trent JM, Parker JS, Raab JR, Weissman BE.
    Elife; 2020 Dec 23; 9():. PubMed ID: 33355532
    [Abstract] [Full Text] [Related]

  • 9. The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type.
    Witkowski L, Goudie C, Ramos P, Boshari T, Brunet JS, Karnezis AN, Longy M, Knost JA, Saloustros E, McCluggage WG, Stewart CJR, Hendricks WPD, Cunliffe H, Huntsman DG, Pautier P, Levine DA, Trent JM, Berchuck A, Hasselblatt M, Foulkes WD.
    Gynecol Oncol; 2016 Jun 23; 141(3):454-460. PubMed ID: 26975901
    [Abstract] [Full Text] [Related]

  • 10. Loss of SMARCA4 Expression Is Both Sensitive and Specific for the Diagnosis of Small Cell Carcinoma of Ovary, Hypercalcemic Type.
    Conlon N, Silva A, Guerra E, Jelinic P, Schlappe BA, Olvera N, Mueller JJ, Tornos C, Jungbluth AA, Young RH, Oliva E, Levine D, Soslow RA.
    Am J Surg Pathol; 2016 Mar 23; 40(3):395-403. PubMed ID: 26645725
    [Abstract] [Full Text] [Related]

  • 11. [Small cell carcinoma of ovary, hypercalcemic type: analysis of clinicopathologic characteristics and the diagnostic utility of loss expression of SMARCA4 protein].
    Wang L, Tan C, Tu X, Zhang Y, Li X, Chang B.
    Zhonghua Bing Li Xue Za Zhi; 2015 Dec 23; 44(12):859-63. PubMed ID: 26888501
    [Abstract] [Full Text] [Related]

  • 12. SMARCA4 inactivating mutations cause concomitant Coffin-Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type.
    Errichiello E, Mustafa N, Vetro A, Notarangelo LD, de Jonge H, Rinaldi B, Vergani D, Giglio SR, Morbini P, Zuffardi O.
    J Pathol; 2017 Sep 23; 243(1):9-15. PubMed ID: 28608987
    [Abstract] [Full Text] [Related]

  • 13. Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Report of a Bilateral Case in a Teenager Associated with SMARCA4 Germline Mutation.
    Lavrut PM, Le Loarer F, Normand C, Grosos C, Dubois R, Buenerd A, Conter C, Dijoud F, Blay JY, Collardeau-Frachon S.
    Pediatr Dev Pathol; 2016 Sep 23; 19(1):56-60. PubMed ID: 26230154
    [Abstract] [Full Text] [Related]

  • 14. The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases.
    Witkowski L, Donini N, Byler-Dann R, Knost JA, Albrecht S, Berchuck A, McCluggage WG, Hasselblatt M, Foulkes WD.
    Fam Cancer; 2017 Jul 23; 16(3):395-399. PubMed ID: 27866340
    [Abstract] [Full Text] [Related]

  • 15. SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas.
    Karanian-Philippe M, Velasco V, Longy M, Floquet A, Arnould L, Coindre JM, Le Naoures-Méar C, Averous G, Guyon F, MacGrogan G, Croce S.
    Am J Surg Pathol; 2015 Sep 23; 39(9):1197-205. PubMed ID: 26135561
    [Abstract] [Full Text] [Related]

  • 16. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4.
    Ramos P, Karnezis AN, Craig DW, Sekulic A, Russell ML, Hendricks WP, Corneveaux JJ, Barrett MT, Shumansky K, Yang Y, Shah SP, Prentice LM, Marra MA, Kiefer J, Zismann VL, McEachron TA, Salhia B, Prat J, D'Angelo E, Clarke BA, Pressey JG, Farley JH, Anthony SP, Roden RB, Cunliffe HE, Huntsman DG, Trent JM.
    Nat Genet; 2014 May 23; 46(5):427-9. PubMed ID: 24658001
    [Abstract] [Full Text] [Related]

  • 17. Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines.
    Tischkowitz M, Huang S, Banerjee S, Hague J, Hendricks WPD, Huntsman DG, Lang JD, Orlando KA, Oza AM, Pautier P, Ray-Coquard I, Trent JM, Witcher M, Witkowski L, McCluggage WG, Levine DA, Foulkes WD, Weissman BE.
    Clin Cancer Res; 2020 Aug 01; 26(15):3908-3917. PubMed ID: 32156746
    [Abstract] [Full Text] [Related]

  • 18. Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.
    Jelinic P, Schlappe BA, Conlon N, Tseng J, Olvera N, Dao F, Mueller JJ, Hussein Y, Soslow RA, Levine DA.
    Mod Pathol; 2016 Jan 01; 29(1):60-6. PubMed ID: 26564006
    [Abstract] [Full Text] [Related]

  • 19. A Population-Based Study of Patients With Small Cell Carcinoma of the Ovary, Hypercalcemic Type, Encompassing a 30-Year Period.
    Blatnik A, Dragoš VŠ, Blatnik O, Stegel V, Klančar G, Novaković S, Drev P, Žagar T, Merlo S, Škof E, Bojadžiski MP, Strojnik K, Krajc M.
    Arch Pathol Lab Med; 2024 Mar 01; 148(3):299-309. PubMed ID: 37270804
    [Abstract] [Full Text] [Related]

  • 20. SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.
    Agaimy A, Thiel F, Hartmann A, Fukunaga M.
    Ann Diagn Pathol; 2015 Oct 01; 19(5):283-7. PubMed ID: 26123103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.